Bioactive compounds from microalgae, produced to specification.
Silex Ocean manufactures pharma-grade carotenoids, omega-3 fatty acids and photosynthetic proteins in controlled photobioreactors in Norway — with full batch traceability and documented release testing.
Every compound supplied with a documented basis
Our strains, cultivation parameters and downstream processing are selected against published literature and regulatory opinions. Each delivery is accompanied by specification and analytical documentation.
We communicate what the evidence supports and nothing beyond it. Claims are referenced to peer-reviewed publications or EFSA opinions, so your regulatory and formulation teams can work from verifiable material.
Six compounds, one controlled process
Select a compound to review its specification basis, documented activity and typical industrial applications.
Fucoxanthin
Brown-algae carotenoid, concentrated and stabilised.
- Documented anti-inflammatory and metabolic activity in peer-reviewed literature
- Neuroprotective activity reported in pre-clinical models
- Naturally co-occurring with EPA in the native algal matrix
References · Marine Drugs, MDPI (2020) · PubMed reviews on fucoxanthin pharmacology
Controlled cultivation, repeatable output
Photobioreactor platform
Closed-system cultivation with controlled light, temperature and nutrient regimes for consistent compound concentration.
Circular operation
Closed-loop, optimised production with minimal waste streams and a net-negative operational footprint.
Quality documentation
Batch traceability from strain to shipment, with release testing and specification sheets for every lot.
From strain selection to released compound
Five controlled stages, applied identically to every batch. Select a stage to review process parameters and quality controls.
Candidate strains are screened before any scale-up.
Microalgae strains from Nordic waters are screened for compound yield, genetic stability and purity. Only qualified candidates enter production.
- Native Nordic strain library
- Purity and potency screening
- Genetic stability verified
Supply into regulated industries
Cosmetics
Fucoxanthin, β-carotene and tocopherols as antioxidant and photoprotective actives.
Marine Drugs (MDPI), 2020
Nutraceuticals
Algal EPA/DHA for cardiovascular and cognitive formats without fish-derived inputs.
EFSA · Journal of Functional Foods, 2021
Pharmaceuticals
Characterised carotenoid fractions for anti-inflammatory and metabolic development programmes.
NIH PubMed reviews, fucoxanthin pharmacology
Clinical & research
Photosynthetic and fluorescent proteins as imaging probes, biosensors and diagnostic reagents.
Nature Methods · Annual Review of Biochemistry
Silex Ocean supplies ingredients and raw materials. Responsibility for finished-product claims and regulatory compliance rests with the finished-product manufacturer.
Discuss supply with Silex Ocean
Request specification sheets, sample material or volume indications for your formulation and development programmes.
Contact the commercial team